Best in Biotech 18 Mar 2025Cancer vaccines: 11 biotechs to keep an eye out for As various biotechs across the world specialize in the production of cancer vaccines, here are 11 companies making progress in the field. March 18, 2025 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 13 Mar 2025Nine biotechs thriving in Seattle in 2025 In this article, let us take a look at some of the major biotech companies in Seattle that are contributing to the biotech industry at large. March 13, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 12 Mar 2025Checkpoint inhibitors in cancer: breakthroughs, setbacks, and what’s next Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field. March 12, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 18 Feb 2025T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments T cell engagers represent a novel approach to tuning the immune system to target and kill tumor cells, expanding treatment options for cancer. February 18, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 4 Feb 2025World Cancer Day: trends in cancer therapeutics to look forward to in 2025 As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer care in 2025. February 4, 2025 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 17 Jan 2025Are PD-1 and PD-L1 checkpoint inhibitors as good as we thought? Checkpoint inhibitors, especially those targeting PD-1 and PD-L1, are exploding in popularity. But how much of it is hype? January 17, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Dec 2024Six biotech companies leading the way in India Discover six of the top biotech companies in India, which is currently brimming with biotechs and a young, skilled workforce. December 30, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 17 Dec 2024Ovarian cancer: BioNTech, Curelab, OvarianVax and more bring vaccines to the clinic A number of ovarian cancer vaccines are being evaluated including the world’s first cancer prevention vaccine, which recently received funding. December 17, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 11 Dec 2024Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy? Find out more about the emerging field of glycobiology, which could potentially lead to a new type of cancer immunotherapy. December 11, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 2 Dec 2024The rise of cancer vaccines: A new era in immunotherapy Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight tumors. December 2, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 31 Oct 2024Five T cell engager companies you should know about Discover five T cell engager companies that have emerged in recent times, as this class of therapeutics is set to take off. October 31, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 30 Oct 2024Spatial Transcriptomics: A window into disease The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How could this change the way we treat disease? October 30, 2024 - 11 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email